| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,016,258 ) |
| | 2025 | 2025 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44AI188623 | A first-in-class product for the clearance of high-risk human papillomaviruses | 000 | 1 | NIH | 12/17/2024 | $1,000,000 |
| | 2025 | 2025 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD101169 | A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women | 000 | 3 | NIH | 12/17/2024 | $1,016,258 |
| | 2025 | 2024 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD101169 | A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women | 002 | 2 | NIH | 2/20/2025 | $82,470 |
| | 2025 | 2023 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R41HD113465 | Therapeutic targeting of FKBP51 for the prevention of stress-induced preterm birth | 000 | 1 | NIH | 12/16/2024 | $0 |
| | 2025 | 2020 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD101169 | A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women | 001 | 1 | NIH | 2/20/2025 | -$82,470 |
|
| Issue Date FY: 2024 ( Subtotal = $959,955 ) |
| | 2024 | 2024 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD101169 | A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women | 000 | 2 | NIH | 12/11/2023 | $991,573 |
| | 2024 | 2022 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R43HD108820 | Defining end-user preferences among US women to optimize the design of a long-acting injectable hormonal contraceptive | 000 | 1 | NIH | 4/4/2024 | $0 |
| | 2024 | 2021 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R43HD107685 | Subcutaneous insertion and removal of a user-controlled, long-acting, and reversible contraceptive device | 000 | 1 | NIH | 12/5/2023 | -$31,618 |
|
| Issue Date FY: 2023 ( Subtotal = $384,972 ) |
| | 2023 | 2023 | DARE BIOSCIENCE, INC. | SUITE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R41HD113465 | Therapeutic targeting of FKBP51 for the prevention of stress-induced preterm birth | 000 | 1 | NIH | 7/28/2023 | $384,972 |
|
| Issue Date FY: 2022 ( Subtotal = $249,336 ) |
| | 2022 | 2022 | DARE BIOSCIENCE, INC. | 3655 NOBEL DR STE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R43HD108820 | Defining end-user preferences among US women to optimize the design of a long-acting injectable hormonal contraceptive | 000 | 1 | NIH | 3/30/2022 | $249,336 |
| | 2022 | 2021 | DARE BIOSCIENCE, INC. | 3655 NOBEL DR STE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R43HD107685 | Subcutaneous insertion and removal of a user-controlled, long-acting, and reversible contraceptive device | 000 | 1 | NIH | 11/18/2021 | $0 |
| | 2022 | 2020 | DARE BIOSCIENCE, INC. | 3655 NOBEL DR STE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD101169 | A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women | 000 | 1 | NIH | 6/14/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $309,614 ) |
| | 2021 | 2021 | DARE BIOSCIENCE, INC. | 3655 NOBEL DR STE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R43HD107685 | Subcutaneous insertion and removal of a user-controlled, long-acting, and reversible contraceptive device | 000 | 1 | NIH | 9/21/2021 | $309,614 |
| | 2021 | 2020 | DARE BIOSCIENCE, INC. | 3655 NOBEL DR STE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD095724 | Safety, and acceptability of a non-hormonal vaginal ring | 000 | 3 | NIH | 8/13/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,030,418 ) |
| | 2020 | 2020 | DARE BIOSCIENCE, INC. | 3655 NOBEL DR STE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD095724 | Safety, and acceptability of a non-hormonal vaginal ring | 000 | 3 | NIH | 3/30/2020 | $730,722 |
| | 2020 | 2020 | DARE BIOSCIENCE, INC. | 3655 NOBEL DR STE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD101169 | A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women | 000 | 1 | NIH | 8/18/2020 | $299,696 |
|
| Issue Date FY: 2019 ( Subtotal = $982,851 ) |
| | 2019 | 2019 | DARE BIOSCIENCE, INC. | 3655 NOBEL DR STE 260 | SAN DIEGO | CA | 92122-1050 | SAN DIEGO | USA | R44HD095724 | Safety, and acceptability of a non-hormonal vaginal ring | 001 | 2 | NIH | 3/6/2019 | $982,851 |
|
|
